Drug Shortage Report for 70% DEXTROSE INJECTION USP

Last updated on 2021-10-17 History
Report ID 147116
Drug Identification Number 02014874
Brand name 70% DEXTROSE INJECTION USP
Common or Proper name 70% Dextrose Injection, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 70G
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3000mL Bag
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-16
Actual start date 2021-10-16
Estimated end date 2021-11-05
Actual end date
Shortage status Actual shortage
Updated date 2021-10-17
Company comments Baxter is experiencing a supply disruption on 70% Dextrose 3L format (Baxter code JB0297) which will continue until the first week of November. Limited supply of the 2L format (Baxter code 2B0296H) is available. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information.
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-10-17 English Compare
v2 2021-10-13 French Compare
v1 2021-10-13 English Compare